Nemolizumab
Nemolizumab (CIM331) is a humanized monoclonal antibody targeting the human interleukin-31 receptor A, inhibiting IL-31 binding and subsequent signal transduction. It is useful for studying atopic dermatitis with pruritus.
Product Specifications
CAS Number
1476039-58-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Interleukin
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
37774064 1.0 µg DNA
Prps1l3 Lentiviral Vector (Mouse) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details GTR10441883 96 Well
Canine Transcription factor SOX 21 (SOX21) ELISA kit
Sign In for Pricing
View Details 